Drug Database
Back to search

Japan· JP-6132418F1165

セフタジジム水和物

A ceftazidime product containing セフタジジム水和物, registered in Japan by ヴィアトリス・ヘルスケア, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

On Japan’s NHI price listATC J01DD02

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedセフタジジム水和物ATCJ01DD02REGISTER NO.JP-6132418F1165PACKS LISTED0CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about セフタジジム水和物Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ceftazidime is registered in 18 of 19 countries.

Countries holding a registration under ATC J01DD02 (ceftazidime), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 10 of them publish a price we can compare per daily dose
Search ceftazidime products by name

Ceftazidime · ATC J01DD02

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ceftazidime costs, country by country.

Normalised to the WHO defined daily dose (4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ceftazidime · price per daily dose (4 g)

USD · FX 28 Sept 2026

  • CH Switzerland$129.98
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
セフタジジム水和物
Manufacturer
ヴィアトリス・ヘルスケア
Country
Japan (JP)
ATC code
J01DD02
ATC class
Ceftazidime
Defined daily dose
4 g, P
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

155 interactions on record for ceftazidime.

Graded by severity as the source publishes them — 34 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ceftazidime against other medicinesHow interaction checks work

Ceftazidime · interactions on record

155 records

  • 34 moderate
  • 121 info

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • NeomycinA07AA01moderate
  • StreptomycinA07AA04moderate
  • Amphotericin BA07AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under J01DD02

Ceftazidime, as other registers publish it.

All ceftazidime products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bdcec79a-7591-44b9-b48b-70799bd36598
GET /v1/drugs/bdcec79a-7591-44b9-b48b-70799bd36598?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "５００ｍｇ１瓶",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "6132418F1165",
  "category": "注射薬",
  "price_yen": 304,
  "generic_name": "セフタジジム水和物",
  "product_name_jp": null,
  "therapeutic_class": "6132",
  "transitional_expiry": null
}
API referenceMCP serverPlans

See everything about ceftazidime.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console